First-in-Man Clinical Trial of the Oral Pan-AKT Inhibitor MK-2206 in Patients With Advanced Solid Tumors.
| Autor: | Yap TA, Yan L, Patnaik A, Fearen I, Olmos D, Papadopoulos K, Baird RD, Delgado L, Taylor A, Lupinacci L, Riisnaes R, Pope LL, Heaton SP, Thomas G, Garrett MD, Sullivan DM, de Bono JS, Tolcher AW |
|---|---|
| Zdroj: | Journal of Clinical Oncology; 12/10/2011, Vol. 29 Issue 35, p4688-4695, 8p |
| Databáze: | Supplemental Index |
| Externí odkaz: |
|